Production of frambinone by a recombinant fungal microorganism

US10793880B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10793880-B2
Application numberUS-201716302527-A
CountryUS
Kind codeB2
Filing dateJun 2, 2017
Priority dateJun 3, 2016
Publication dateOct 6, 2020
Grant dateOct 6, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a genetically modified fungal microorganism for the production of frambinone, the microorganism having the following characteristics: —the capacity to produce frambinone from tyrosine; and —a limited capacity or no capacity to break tyrosine down into tyrosol, p-hydroxyphenylacetaldehyde and/or p-hydroxyphenylacetate; and to the use of same for producing frambinone.

First claim

Opening claim text (preview).

The invention claimed is: 1. A genetically modified fungal microorganism for the production of frambinone, said microorganism having the following characteristics: a capacity to produce frambinone from tyrosine; and a limited capacity or no capacity to break tyrosine down into tyrosol, p-hydroxyphenylacetaldehyde and/or p-hydroxyphenylacetate, wherein said genetically modified fungal microorganism has hydroxyphenyl pyruvate decarboxylase (HPPDC) activity less than or equal to 2×10 −6 kat per g of protein, and comprises at least one mutation or deletion in at least one of the genes encoding the following enzymes: deaminase Aro8, deaminase Aro9, decarboxylase Aro10, decarboxylase Pdc5, decarboxylase Pdc6, or alcohol dehydrogenase (ADH). 2. The microorganism according to claim 1 characterized in that the microorganism belongs to the phyla ascomycetes or basidiomycetes. 3. The microorganism of claim 1 characterized in that the microorganism includes at least one heterologous sequence encoding the enzyme 4-coumarate: CoA ligase (4CL) or benzalacetone synthase (BAS). 4. The microorganism according to claim 3 characterized in that the microorganism additionally comprises at least one heterologous or supernumerary sequence encoding the enzyme tyrosine ammonia lyase (TAL) or benzalacetone reductase (BAR). 5. The microorganism according to claim 3 characterized in that the microorganism additionally comprises at least one heterologous or supernumerary sequence encoding the enzyme phenylalanine ammonia lyase (PAL) or cinnamate 4 hydroxylase (C4H). 6. The microorganism according to claim 1 which is the strain Saccharomyces cerevisiae RK8, registered with the CNCM (National Collection of Microorganism Cultures, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15) on Apr. 26, 2017 under number I-5200. 7. The microorganism according to claim 1 characterized in that the microorganism belongs to the genus Yarrowia, Debaryomyces, Arxula, Scheffersomyces, Geotrichum, Pichia , or Saccharomyces. 8. The microorganism according to claim 1 characterized in that the microorganism is belongs to the species Yarrowia lipolytica, Debaryomyces hansenii , or Saccharomyces cerevisiae. 9. The microorganism of claim 3 characterized in that the microorganism includes at least one heterologous sequence encoding 4CL and BAS, at least one heterologous or supernumerary sequence encoding TAL and BAR, and/or at least one heterologous or supernumerary sequence encoding PAL or C4H. 10. The microorganism according to claim 1 characterized in that the microorganism comprises at least one mutation or deletion in at least one of the genes encoding Aro10, Pdc5, and/or Pdc6. 11. A process for the production of frambinone comprising culturing the fungal microorganism according to claim 1 in a medium comprising tyrosine. 12. A process for the production of frambinone comprising culturing the fungal microorganism according to claim 1 with a capacity to produce frambinone from tyrosine in a medium comprising tyrosine and a repressor of the path for breaking tyrosine down into tyrosol, p-hydroxyphenylacetaldehyde and/or p-hydroxyphenylacetate. 13. The process for the production of frambinone according to claim 12 characterized in that the repressor is glutamate. 14. The process for the production of frambinone according to claim 12 characterized in that the microorganism belongs to the phyla chosen from among the ascomycetes or basidiomycetes, includes at least one heterologous sequence encoding the enzyme 4-coumarate: CoA ligase (4CL) or benzalacetone synthase (BAS), comprises at least one heterologous or supernumerary sequence encoding the enzyme tyrosine ammonia lyase (TAL) or benzalacetone reductase (BAR), and comprises at least one heterologous or supernumerary sequence encoding the enzyme phenylalanine ammonia lyase (PAL) or cinnamate 4 hydroxylase (C4H). 15. The process for the production of frambinone according to claim 12 characterized in that the microorganism is the industrial strain Saccharomyces cerevisiae RK4 registered with the CNCM on Jun. 1, 2016 under number I-5101. 16. The process for the production of frambinone according to claim 12 characterized in that the microorganism is the industrial strain Saccharomyces cerevisiae RK5 registered with the CNCM on Apr. 26, 2017 under number I-5199.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10793880B2 cover?
The invention relates to a genetically modified fungal microorganism for the production of frambinone, the microorganism having the following characteristics: —the capacity to produce frambinone from tyrosine; and —a limited capacity or no capacity to break tyrosine down into tyrosol, p-hydroxyphenylacetaldehyde and/or p-hydroxyphenylacetate; and to the use of same for producing frambinone.
Who is the assignee on this patent?
Lesaffre & Cie
What technology area does this patent fall under?
Primary CPC classification C12P7/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).